43 results match your criteria Clinical Medicine Insights: Reproductive Health [Journal]

  • Page 1 of 1

An investigation into mistreatment of women during labour and childbirth in maternity care facilities in Uttar Pradesh, India: a mixed methods study.

Reprod Health 2019 Jan 23;16(1). Epub 2019 Jan 23.

Deputy Manager-Research, Sambodhi Research and Communications, O-2, Lajpat Nagar-II, New Delhi, 110024, India.

Objectives: To investigate the nature and context of mistreatment during labour and childbirth at public and private sector maternity facilities in Uttar Pradesh, India.

Methods: This study analyses mixed-methods data obtained through systematic clinical observations and open-ended comments recorded by the observers to describe care provision for 275 mothers and their newborns at 26 hospitals in three districts of Uttar Pradesh from 26 May to 8 July 2015. We conducted a bivariate descriptive analysis of the quantitative data and used a thematic approach to analyse qualitative data. Read More

View Article

Download full-text PDF

Source
https://reproductive-health-journal.biomedcentral.com/articl
Publisher Site
http://dx.doi.org/10.1186/s12978-019-0668-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345007PMC
January 2019
6 Reads

Seroprevalences and Correlates of Hepatitis B and C Among Cameroonian Pregnant Women.

Clin Med Insights Reprod Health 2018 16;12:1179558118770671. Epub 2018 Apr 16.

Faculty of Health Sciences, School of Armies Health Services of Lomé, University of Lomé, Lomé, Togo.

Background And Rationale: Viral hepatitis B (VHB) and viral hepatitis C (VHC) are major public health issues in resource-poor countries where vertical transmission remains high.

Aim: To assess prevalences and correlates of VHB and VHC among women attending antenatal clinic.

Methods: A cross-sectional study at the Yaounde Central Hospital from January 1 to June 30, 2016. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1179558118770671DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909852PMC
April 2018
41 Reads

Protection for Children Born Through Assisted Reproductive Technologies Act, B.E. 2558: The Changing Profile of Surrogacy in Thailand.

Authors:
Alessandro Stasi

Clin Med Insights Reprod Health 2017 20;11:1179558117749603. Epub 2017 Dec 20.

Mahidol University International College (MUIC), Salaya, Thailand.

The National Legislative Assembly of Thailand has enacted on February 19, 2015 the Protection for Children Born through Assisted Reproductive Technologies Act (ART Act). Its primary objective aims at protecting children born through assisted reproductive technologies and providing the legal procedures that the intended parents must follow. The focus of this article is to discuss the ongoing issues involving assisted reproduction in Thailand. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1179558117749603DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753847PMC
December 2017
9 Reads

The Impact of Complications on Patients' Assessment of the Outcome of Tension-Free Vaginal Tape Procedure.

Clin Med Insights Reprod Health 2017 15;11:1179558117742374. Epub 2017 Nov 15.

Rural Clinical School, Faculty of Medicine, The University of Queensland, Rockhampton, QLD, Australia.

Introduction: Our study aimed to assess the impact of managed complications of tension-free vaginal tape (TVT) on the patients' assessment of the results as measured by Patient Global Impression of Improvement (PGI-I).

Materials And Methods: This was a retrospective study, supplemented with a telephone interview, comparing patients who had complications of TVT procedures with those where no complications recorded. The primary outcome was the PGI-I score in the 2 groups. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1179558117742374DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5692124PMC
November 2017
10 Reads

Modern Contraceptive Choice Among Patients Seen at the "Cameroon National Planning Association for Family Welfare" Clinic Yaoundé.

Clin Med Insights Reprod Health 2017 22;11:1179558117713016. Epub 2017 Jun 22.

Department of Obstetrics and Gynecology, Faculty of Medicine and BioMedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.

Background: To understand the low modern contraceptive prevalence in Cameroon, we reviewed the methods chosen and determined their side effects among patients in an urban setting.

Methods: We conducted a cross-sectional study at the "Cameroon National Planning Association for Family Welfare (CAMNAFAW) Clinic" in Yaoundé. Data were processed by SPSS software version 20. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1179558117713016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484599PMC
June 2017
8 Reads

Case Report of Ectopic Ovarian Pregnancy Following Fresh Embryo Transfer.

Clin Med Insights Reprod Health 2016 14;10:29-32. Epub 2016 Nov 14.

Department of Obstetrics and Gynecology, TRIO Fertility Clinic, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.

Background: Ovarian pregnancy is a rare and challenging clinical phenomenon. Recent studies have identified assisted reproductive treatments and infertility as risk factors. However, neither a definite mechanism nor clear risk factors were identified and therefore prevention strategies are yet unavailable. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S40593DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110221PMC
November 2016
9 Reads

Femilis(®) 60 Levonorgestrel-Releasing Intrauterine System-A Review of 10 Years of Clinical Experience.

Clin Med Insights Reprod Health 2016 9;10:19-27. Epub 2016 Aug 9.

Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Western Cape, South Africa.

Objective: The aim of this study was to update the clinical experience with the Femilis® 60 levonorgestrel-releasing intrauterine system (LNG-IUS), now up to 10 years in parous and nulliparous women, particularly with regard to ease and safety of insertion, contraceptive performance, retention, acceptability, continuation of use, impact on menstrual blood loss (MBL), and duration of action.

Study Design: Using the Femilis® 60 LNG-IUS releasing 20 µg of levonorgestrel/day, the following studies were conducted: an open, prospective noncomparative contraceptive study, an MBL study, a perimenopausal study, a study for the treatment of endometrial hyperplasia, and early cancer of the uterus, a residue study.

Results: A total of 599 Femilis LNG-IUS were inserted in various clinical trials, the majority for contraceptive purposes. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S40087DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979586PMC
August 2016
13 Reads

Accurate Point-of-Care Detection of Ruptured Fetal Membranes: Improved Diagnostic Performance Characteristics with a Monoclonal/Polyclonal Immunoassay.

Clin Med Insights Reprod Health 2016 9;10:15-8. Epub 2016 May 9.

Independent Clinical Consultant, San Francisco, CA, USA.

Objective: Accurate and timely diagnosis of rupture of membranes (ROM) is imperative to allow for gestational age-specific interventions. This study compared the diagnostic performance characteristics between two methods used for the detection of ROM as measured in the same patient.

Methods: Vaginal secretions were evaluated using the conventional fern test as well as a point-of-care monoclonal/polyclonal immunoassay test (ROM Plus(®)) in 75 pregnant patients who presented to labor and delivery with complaints of leaking amniotic fluid. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S38386DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862745PMC
May 2016
41 Reads

Cortisol-Metabolizing Enzymes in Polycystic Ovary Syndrome.

Clin Med Insights Reprod Health 2016 5;10:9-13. Epub 2016 May 5.

Rappaport Family Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Objective: The aim of this study was to assess the activity of cortisol-metabolizing enzymes in women with polycystic ovary syndrome (PCOS), using a fully quantitative gas chromatography/mass spectrometry (GCMS) method.

Design: We investigated the glucocorticoid degradation pathways that include 11β-hydroxysteroid dehydrogenase (11β-HSD) type 1, 5α-reductase (5α-R) and 5β-reductase (5β-R), 3α-hydroxysteroid dehydrogenase, and 20α- and 20β-hydroxysteroid dehydrogenase (20α-HSD and 20β-HSD, respectively) in young nonobese women with PCOS, using a fully quantitative GCMS method.

Setting: This study was conducted in a tertiary referral hospital in Israel. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S35567DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859446PMC
May 2016
14 Reads

Relevance of Imaging Examinations in the Surgical Planning of Patients with Bowel Endometriosis.

Clin Med Insights Reprod Health 2016 21;10:1-8. Epub 2016 Feb 21.

Department of Gynecology, Sugisawa Medical Center, Curitiba, Paraná, Brazil; Department of Gynecology, Vita Batel Hospital, Curitiba, Paraná, Brazil.

Endometriosis is a benign gynecologic disease characterized by the presence of endometrial tissue outside the uterine cavity. The complexity of the disease results from its multiple clinical presentations, the multifocal pattern of distribution of the lesions, the presence of extra pelvic sites of the disease (mainly affecting the urinary and the intestinal tracts), and the difficulty in the preoperative diagnosis (by means of imaging studies) and in the surgical treatment. The preoperative mapping of the lesions, either by ultrasound or by magnetic resonance imaging, allows for an adequate surgical planning and a better preoperative patient counseling, especially in those women with deep infiltrating endometriosis affecting the bowel. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CMRH.S29472
Publisher Site
http://dx.doi.org/10.4137/CMRH.S29472DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762458PMC
February 2016
10 Reads

Cryptorchidism and Fertility.

Clin Med Insights Reprod Health 2015 22;9:39-43. Epub 2015 Dec 22.

Professor of Urology, Faculty of Medicine, Cairo University, Cairo, Egypt.

Cryptorchidism, the failure of one or both testes to descend into the scrotum prenatally, occurs in 2.4%-5% of newborns. Many of these testes will descend spontaneously shortly after birth, but ~23% will remain undescended unless surgery is performed. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CMRH.S25056
Publisher Site
http://dx.doi.org/10.4137/CMRH.S25056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689328PMC
January 2016
14 Reads

The IMSI Procedure Improves Laboratory and Clinical Outcomes Without Compromising the Aneuploidy Rate When Compared to the Classical ICSI Procedure.

Clin Med Insights Reprod Health 2015 12;9:29-37. Epub 2015 Nov 12.

FERTILAB Laboratory of Assisted Reproduction, Lima, Perú.

Purpose: The intracytoplasmic morphologically selected sperm injection (IMSI) procedure has been associated with better laboratory and clinical outcomes in assisted reproduction technologies. Less information is available regarding the relationship between embryo aneuploidy rate and the IMSI procedure. The aim of this study is to compare the clinical outcomes and chromosomal status of IMSI-derived embryos with those obtained from intracytoplasmic sperm injection (ICSI) in order to establish a clearer view of the benefits of IMSI in infertile patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S33032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644143PMC
November 2015
17 Reads

High Aneuploidy Rates Observed in Embryos Derived from Donated Oocytes are Related to Male Aging and High Percentages of Sperm DNA Fragmentation.

Clin Med Insights Reprod Health 2015 11;9:21-7. Epub 2015 Nov 11.

FERTILAB Laboratory of Assisted Reproduction, Lima, Perú. ; PROCREAR Fertility Center, Lima, Perú.

Capsule: Male aging effects on aneuploidy rates in embryos.

Objective: Paternal age is associated with decreasing sperm quality; however, it is unknown if it influences chromosomal abnormalities in embryos. The objective of this study is to evaluate if the aneuploidy rates in embryos are affected by advanced paternal age. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S32769DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642825PMC
November 2015
9 Reads

Combination of PAPPA, fhCGβ, AFP, PlGF, sTNFR1, and Maternal Characteristics in Prediction of Early-onset Preeclampsia.

Clin Med Insights Reprod Health 2015 11;9:13-20. Epub 2015 Jun 11.

Department of Obstetrics and Gynecology, Oulu University Hospital, Oulu, Finland.

Objective: To evaluate the efficacy of first-trimester markers-pregnancy-associated plasma protein A (PAPPA), free human chorionic gonadotropin β (fhCGβ), alpha-fetoprotein (AFP), placental growth factor (PlGF), and soluble tumor necrosis factor receptor-1 (sTNFR1) together with maternal characteristics (MC) for prediction of early-onset preeclampsia (EOPE).

Methods: During 2005-2010, the abovementioned biomarkers were analyzed with logistic regression analysis in 64 EOPE and 752 control subjects to determine whether these biomarkers separately and in combination with MC would predict development of EOPE.

Results: PAPPA, fhCGβ, and PlGF levels were lower, whereas AFP and sTNFR1 levels were higher in mothers with EOPE compared to controls. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S21865DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469033PMC
June 2015
13 Reads

In Vivo Culture System Using the INVOcell Device Shows Similar Pregnancy and Implantation Rates to Those Obtained from In Vivo Culture System in ICSI Procedures.

Clin Med Insights Reprod Health 2015 10;9:7-11. Epub 2015 Jun 10.

FERTILAB Laboratory of Assisted Reproduction, Lima, Peru. ; PROCREAR Fertility Center, Lima, Peru.

Capsule: Clinical outcomes using INVOcell device with ICSI.

Objective: Intravaginal culture of oocytes (INVO) procedure is an intravaginal culture system that utilizes the INVOcell device in which the fertilization and embryo culture occur. In this procedure, the vaginal cavity serves as an incubator for oocyte fertilization and early embryonic development. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CMRH.S25494
Publisher Site
http://dx.doi.org/10.4137/CMRH.S25494DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463795PMC
June 2015
17 Reads

The Role of Uterine and Umbilical Arterial Doppler in High-risk Pregnancy: A Prospective Observational Study from India.

Clin Med Insights Reprod Health 2015 15;9:1-5. Epub 2015 Apr 15.

Department of Medical and Pediatric Oncology, GCRI, Ahmedabad, Gujarat, India.

Aim: To study the role of Doppler imaging in prediction of high-risk pregnancies and their outcomes.

Methods And Material: This prospective study in a setup of tertiary-level care center includes 500 high-risk pregnant women from rural and urban sectors and evaluates the predictive values of various Doppler indices.

Results: Out of 500 patients, 110 patients had abnormal Doppler among them, 70 patients had abnormal uterine artery Doppler, and 50 patients had abnormal umbilical artery Doppler flow indices. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S24048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401238PMC
April 2015
19 Reads
1 Citation

Individualized Treatment from Theory to Practice: The Private Case of Adding LH during GnRH Antagonist-based Stimulation Protocol.

Authors:
Shahar Kol

Clin Med Insights Reprod Health 2014 14;8:59-64. Epub 2014 Oct 14.

IVF Unit Rambam Health Care Campus, Maccabi Healthcare Services and the Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.

Unlabelled: The study evaluated the proportion of patients whose pituitary glands respond with a sharp decrease in luteinizing hormone (LH) levels when exposed to a conventional dose of 0.25 mg gonadotropin releasing hormone (GnRH) antagonist in a prospective, single-center, non-randomized, proof-of-concept study. Fifty women eligible for in vitro fertilization (IVF) received recFSH (Gonal-F) from day 2 or 3 of menstrual period. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S17788DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213184PMC
December 2014
17 Reads

The Low Prevalence of Y Chromosomal Microdeletions is Observed in the Oligozoospermic Men in the Area of Mato Grosso State and Amazonian Region of Brazilian Patients.

Clin Med Insights Reprod Health 2014 11;8:51-7. Epub 2014 Aug 11.

Department of Gynecology and Obstetrics, Faculty of Medicine, UFMT, Cuiabá, MT, Brazil. ; Tropical Institute of Reproductive Medicine and Menopause, Cuiabá, MT, Brazil.

Objective: To determine the prevalence of chromosomal abnormalities and microdeletions on Y chromosome in infertile patients with oligozoospermia or azoospermia in Mato Grosso state, Brazil.

Methods: This cross-sectional study enrolled 94 men from infertile couples. Karyotype analysis was performed by lymphocyte culture technique. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S15475DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133943PMC
September 2014
15 Reads

Combined first-trimester screening in northern Finland: experiences of the first ten years.

Clin Med Insights Reprod Health 2014 30;8:45-9. Epub 2014 Jul 30.

Department of Obstetrics and Gynecology, Oulu University Hospital, Finland.

Objective: To evaluate the efficacy of first trimester combined screening for Down's syndrome in Northern Finland during the first 10 years of practice.

Methods: During 1 January 2002 to 31 December 2011, 47,896 women participated voluntarily in combined screening during first trimester. The risk cutoff was 1:250. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S14958DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130568PMC
August 2014
9 Reads

Ketoconazole inhibits ovulation as a result of arrest of follicular steroidogenesis in the rat ovary.

Clin Med Insights Reprod Health 2014 9;8:37-44. Epub 2014 Jun 9.

Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.

Objective: Ketoconazole (KCZ) is a known inhibitor of steroidogenic P450 enzymes in the adrenal cortex and the gonads. Previous studies examined the potential clinical use of KCZ for attenuation of ovarian response to gonadotropin treatments. This study aimed to use the superovuating rat model to explore the effect of KCZ on ovarian steroidogenesis, follicular function, and development toward ovulation. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CMRH.S15887
Publisher Site
http://dx.doi.org/10.4137/CMRH.S15887DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071760PMC
July 2014
25 Reads

Coenzyme Q10 Supplementation and Oocyte Aneuploidy in Women Undergoing IVF-ICSI Treatment.

Clin Med Insights Reprod Health 2014 8;8:31-6. Epub 2014 Jun 8.

Toronto Centre for Advanced Reproductive Technology, Toronto, Ontario, Canada. ; Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Toronto, Toronto, Ontario, Canada. ; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.

Background: The age-related reduction in live-birth rate is attributed to a high rate of aneuploidy and follicle depletion. We showed in an animal model that treatment with Coenzyme Q10 (CoQ10) markedly improved reproductive outcome. The aim of this study was to compare the post-meiotic oocyte aneuploidy rate in in vitro fertilization (IVF) and intra cytoplasmic sperm injection (ICSI) patients treated with CoQ10 or placebo. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S14681DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071761PMC
July 2014
28 Reads

Management of Vaginal Atrophy: Implications from the REVIVE Survey.

Clin Med Insights Reprod Health 2014 8;8:23-30. Epub 2014 Jun 8.

Southern California Center for Sexual Health and Survivorship Medicine, Newport Beach, CA, USA.

Vulvar and vaginal atrophy (VVA) is a chronic and progressive medical condition common in postmenopausal women. Symptoms of VVA such as dyspareunia, vaginal dryness, irritation, and itching can negatively impact sexual function and quality of life. The REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey assessed knowledge about VVA and recorded attitudes about interactions with healthcare providers (HCPs) and available treatment options for VVA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S14498DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071759PMC
July 2014
6 Reads

Selective inhibition of steroidogenic enzymes by ketoconazole in rat ovary cells.

Clin Med Insights Reprod Health 2014 17;8:15-22. Epub 2014 Feb 17.

Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.

Objective: Ketoconazole (KCZ) is an anti-fungal agent extensively used for clinical applications related to its inhibitory effects on adrenal and testicular steroidogenesis. Much less information is available on the effects of KCZ on synthesis of steroid hormones in the ovary. The present study aimed to characterize the in situ effects of KCZ on steroidogenic enzymes in primary rat ovary cells. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S14036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007567PMC
May 2014
8 Reads
2 Citations

Educational effects of a tailored leaflet addressing drinking during pregnancy.

Clin Med Insights Reprod Health 2014 13;8:5-14. Epub 2014 Jan 13.

Associate Professor, Graduate School of Humanities and Sciences, Ochanomizu University, Otsuka, Bunkyo-ku, Tokyo, Japan.

Objective: To examine the educational effects of a tailored leaflet on current drinking behavior, thoughts about drinking alcohol during pregnancy, and knowledge of fetal alcohol syndrome (FAS) among pregnant women.

Design: Intervention.

Participants: We recruited pregnant women who were participating in maternity classes held at five municipal health centers in Saitama Prefecture and Tokyo in Japan. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S13461DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007566PMC
May 2014
7 Reads

A rare case of chronic ectopic pregnancy presenting as large hematosalpinx.

Clin Med Insights Reprod Health 2014 6;8:1-4. Epub 2014 Jan 6.

Department of Obstetrics and Gynecology, Kamineni Institute of Medical Sciences, Narketpally, Andhra Pradesh, India.

Ectopic pregnancy is defined as implantation and subsequent development of an embryo outside the uterine lining. It has wide range of presentation from acute hemoperitoneum to chronic ectopic pregnancy. This is an unusual case of chronic ectopic pregnancy with large hematosalpinx without classical symptoms. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S13110DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007565PMC
May 2014
22 Reads

Live birth from previously vitrified oocytes, after trophectoderm biopsy, revitrification, and transfer of a euploid blastocyst.

Clin Med Insights Reprod Health 2013 Sep 10;7:79-82. Epub 2013 Sep 10.

The NYU Fertility Center, NYU Langone Medical Center, New York, New York, USA.

Our objective is to describe a successful live birth from oocyte vitrification followed by thaw, fertilization, blastocyst culture, trophectoderm biopsy, vitrification, and subsequent thaw. Fifteen mature oocytes were frozen from a patient with uterine factor infertility. Thirteen oocytes survived the thaw, and five underwent trophectoderm biopsy and were refrozen. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S11919DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888074PMC
September 2013
20 Reads

Robotics in Gynecology: Why is this Technology Worth Pursuing?

Clin Med Insights Reprod Health 2013 Jul 24;7:71-7. Epub 2013 Jul 24.

Centro Médico ABC, Mexico City, Mexico.

Robotic laparoscopy in gynecology, which started in 2005 when the Da Vinci Surgical System (Intuitive Surgical Inc) was approved by the US Food and Drug Administration for use in gynecologic procedures, represents today a modern, safe, and precise approach to pathology in this field. Since then, a great deal of experience has accumulated, and it has been shown that there is almost no gynecological surgery that cannot be approached with this technology, namely hysterectomy, myomectomy, sacrocolpopexia, and surgery for the treatment of endometriosis. Albeit no advantages have been observed over conventional laparoscopy and some open surgical procedures, robotics do seem to be advantageous in highly complicated procedures when extensive dissection and proper anatomy reestablishment is required, as in the case of oncologic surgery. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CMRH.S10850
Publisher Site
http://dx.doi.org/10.4137/CMRH.S10850DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888078PMC
July 2013
8 Reads

Fertility preservation options after gonadotoxic chemotherapy.

Clin Med Insights Reprod Health 2013 Apr 25;7:61-9. Epub 2013 Apr 25.

Department of Obstetrics and Gynecology, McGill University, Montreal, QC, Canada. ; Professor and Academic Vice Chairman of Obstetrics and Gynecology, Milton Leong Chair in Reproductive Medicine, McGill University.

Chemotherapy has the potential to deplete and destroy a woman's reproductive potential. Although many oncologists are referring women for fertility preservation before chemotherapy, in many cases there is limited time for fertility preservation. This review provides an overview of the impact of cancer and chemotherapy on the ovarian reserve, a summary of methods of fertility preservation prior to chemotherapy, and current knowledge of fertility preservation techniques after gonadotoxic chemotherapy. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CMRH.S10848
Publisher Site
http://dx.doi.org/10.4137/CMRH.S10848DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888081PMC
April 2013
13 Reads

Fertility preservation in gynecological cancers.

Clin Med Insights Reprod Health 2013 Mar 21;7:49-59. Epub 2013 Mar 21.

Obstetrics Gynecology, Mahatma Gandhi Institute of Medical Sciences, Sevagram, Wardha, Maharashtra, India.

For cancers of reproductive system in women, fertility preservation is complex. Fertility is also affected by therapies, however prevention is possible. Radiotherapy affects gonads, uterus, and subsequent pregnancy outcomes in all ages. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CMRH.S10794
Publisher Site
http://dx.doi.org/10.4137/CMRH.S10794DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888069PMC
March 2013
8 Reads

Ovarian Stem Cells-the Pros and Cons.

Clin Med Insights Reprod Health 2013 Mar 20;7:43-7. Epub 2013 Mar 20.

8 Ha'Aliyah St., Reproductive Endocrinology Dept. OB/GYN, Rambam Health Care Campus and Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa, Israel.

The potential for postnatal de novo oogenesis in mammals and in humans has become very controversial in the fields of reproductive science and biology. Historically, it has been thought that females of most mammalian species lose the ability to produce oocytes at birth. A contemporary understanding of stem cell biology together with novel experimental methods has challenged the model of a prenatal fixed ovarian primordial follicle pool that declines with age. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S11086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888079PMC
March 2013
6 Reads

Preimplantation genetic screening: a practical guide.

Clin Med Insights Reprod Health 2013 Feb 27;7:37-42. Epub 2013 Feb 27.

Fertility Associates of Memphis, Memphis, TN.

The past several decades have seen tremendous advances in the field of medical genetics. The application of genetic technologies to the field of reproductive medicine has ushered in a new era of medicine that is likely to greatly expand in the coming years. Concurrent with an in vitro fertilization (IVF) cycle, it is now possible to obtain a cellular biopsy from a developing embryo and genetically evaluate this sample with increasing sophistication and detail. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S10852DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888082PMC
February 2013
7 Reads

Emerging options for emergency contraception.

Clin Med Insights Reprod Health 2013 Feb 18;7:23-35. Epub 2013 Feb 18.

Department of Emergency Medicine, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA.

Emergency post-coital contraception (EC) is an effective method of preventing pregnancy when used appropriately. EC has been available since the 1970s, and its availability and use have become widespread. Options for EC are broad and include the copper intrauterine device (IUD) and emergency contraceptive pills such as levonorgestrel, ulipristal acetate, combined oral contraceptive pills (Yuzpe method), and less commonly, mifepristone. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CMRH.S8145
Publisher Site
http://dx.doi.org/10.4137/CMRH.S8145DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888080PMC
February 2013
13 Reads

Preimplantation genetic testing in the 21st century: uncharted territory.

Authors:
Paul R Brezina

Clin Med Insights Reprod Health 2013 Feb 10;7:17-21. Epub 2013 Feb 10.

Director of Reproductive Genetics Fertility Associates of Memphis Memphis, TN.

The past hundred years have given birth to arguably the most profound changes in society, medicine, and technology the world has ever witnessed. Genetics is one such field that has enjoyed a meteoric rise during this time. Progressing from Mendelian genetics to the discovery of DNA to the ability to sequence the human genome, perhaps no other discipline holds more promise to affect future change than genetics. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S10914DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888077PMC
February 2013
9 Reads

Trends in hysterectomy for genital prolapse: rural experience.

Clin Med Insights Reprod Health 2013 Jan 29;7:11-6. Epub 2013 Jan 29.

Obstetrics and Gynaecology, Mahatma Gandhi Institute of Medical Sciences, Sevagram, Wardha, Maharashtra, India.

The present study was conducted to investigate the trends of vaginal hysterectomy for genital prolapse in last 20 years by analyzing case records of affected women. During the analysis period, 4831 women underwent hysterectomy; records of 4223 (87.5%) were available. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CMRH.S10804
Publisher Site
http://dx.doi.org/10.4137/CMRH.S10804DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888075PMC
January 2013
12 Reads

The participation of prospective fathers in preconception care.

Clin Med Insights Reprod Health 2013 Jan 22;7:1-9. Epub 2013 Jan 22.

Versys Clinics, Human Reproduction Institute, Budapest, Hungary.

We present the data of male participants in the Coordinating Center of the Hungarian Preconception Service (HPS), Budapest, 1984-2010. One of main objectives of the HPS was the incorporation of male partners of female participants into the preparation of childbirth. The HPS is based on three steps: (I) Reproductive health check-up. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S10930DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888083PMC
January 2013
8 Reads

Ovarian Damage During chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility.

Clin Med Insights Reprod Health 2012 Oct;2012(6):9-18

Department of Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI, USA.

Women with autoimmune diseases such as lupus, scleroderma, and vasculitis receiving cyclophosphamide for severe disease manifestations risk primary ovarian insufficiency(POI) due to gonadotoxicity of this therapy. In addition to loss of reproductive potential, POI is associated with increased risk of morbidity and mortality. Practitioners caring for women requiring gonadotoxic therapies should be familiar with long-term health implications of POI and strategies for ovarian preservation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S10415DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747568PMC
October 2012
23 Reads

Monitoring maternal Beta carotene and retinol consumption may decrease the incidence of neurodevelopmental disorders in offspring.

Authors:
Joel S Goldberg

Clin Med Insights Reprod Health 2011 Dec 19;6:1-8. Epub 2011 Dec 19.

Durham Veterans Affairs Medical Center and Duke University, 508 Fulton Street, Durham, NC, 27705.

Retinoic acids (13-cis and 13-trans) are known teratogens, and their precursor is retinol, a form of vitamin A. In 1995, Rothman et al demonstrated an association between excessive vitamin A, >10,000 IU/day, during the first trimester of pregnancy and teratogenic effects, particularly in the central nervous system. However, vitamin A deficiency has long been known to be deleterious to the mother and fetus. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CMRH.S8372
Publisher Site
http://dx.doi.org/10.4137/CMRH.S8372DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888066PMC
December 2011
10 Reads

The new extended-cycle levonorgestrel-ethinyl estradiol oral contraceptives.

Clin Med Insights Reprod Health 2011 Sep 19;5:49-54. Epub 2011 Sep 19.

Associate Program Director and Site Director, Internal Medicine Residency Program, Allegheny General Hospital, and Assistant Professor of Medicine, Drexel University College of Medicine, Pittsburgh, PA, USA.

Effective contraceptive counseling requires an understanding of a woman's preferences and medical history as well as the risks, benefits, side effects, and contraindications of each contraceptive method. Hormonal contraceptives using a variety of delivery methods are highly effective and this review highlights the new extended-cycle levonorgestrel-ethinyl estradiol contraceptives. Extended-cycle OCPs are unique in offering fewer or no withdrawal bleeds over the course of one year but providers need to carefully counsel women regarding the initial increased breakthrough bleeding. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CMRH.S5030
Publisher Site
http://dx.doi.org/10.4137/CMRH.S5030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888068PMC
September 2011
8 Reads

Comparison between Cleavage Stage versus Blastocyst Stage Embryo Transfer in an Egyptian Cohort Undergoing in vitro Fertilization: A Possible Role for Laser Assisted Hatching.

Clin Med Insights Reprod Health 2011 Aug 29;5:41-8. Epub 2011 Aug 29.

Department of Obstetrics and Gynecology, Ain Shams University, Cairo, Egypt.

Background: Extended in vitro embryo culture and blastocyst transfer have emerged as essential components of the advanced reproductive technology armamentarium, permitting selection of more advanced embryos considered best suited for transfer.

Aim Of Study: The aim of this study was to compare between cleavage stage and blastocyst stage embryo transfer in patients undergoing intracytoplasmic sperm injection, and to assess the role of assisted hatching technique in patients undergoing blastocyst transfer.

Patients And Methods: This study was carried out on two groups. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CMRH.S7735
Publisher Site
http://dx.doi.org/10.4137/CMRH.S7735DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888070PMC
August 2011
9 Reads

Efficacy of dapoxetine in the treatment of premature ejaculation.

Authors:
Chris G McMahon

Clin Med Insights Reprod Health 2011 Aug 2;5:25-39. Epub 2011 Aug 2.

Australian Centre for Sexual Health, Sydney, NSW, Australia.

Introduction: Premature ejaculation (PE) is a common male sexual disorder which is associated with substantial personal and interpersonal negative psychological factors. Pharmacotherapy of PE with off-label antidepressant SSRI drugs is common. Development and regulatory approval of drugs specifically for the treatment of PE will reduce reliance on off-label treatments and serve to fill a unmet treatment need. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CMRH.S7337
Publisher Site
http://dx.doi.org/10.4137/CMRH.S7337DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888071PMC
August 2011
14 Reads

Pregnancy related complications in patients with systemic lupus erythematosus, an egyptian experience.

Clin Med Insights Reprod Health 2011 May 12;5:17-24. Epub 2011 May 12.

Department of Community Medicine, Misr University for Sciences and Technology, Cairo, Egypt.

Background: Systemic Lupus Erythematosus (SLE) has a tendency to occur in women in their reproductive years, causing complications during pregnancy and labour. Conversely, pregnancy can cause flares of disease activity, often necessitating immediate intervention.

Aim Of Study: to study pregnancy related complications in patients with SLE. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CMRH.S6862
Publisher Site
http://dx.doi.org/10.4137/CMRH.S6862DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888067PMC
May 2011
8 Reads

Letrozole versus Clomiphene Citrate for Induction of Ovulation in Patients with Polycystic Ovarian Syndrome Undergoing Intrauterine Insemination.

Clin Med Insights Reprod Health 2011 Mar 14;5:11-6. Epub 2011 Mar 14.

Endocrinology Unit, National Research Center, Cairo, Egypt.

Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies affecting women in the reproductive age group, and is one of the most common causes of hyperandrogenic anovulatory infertility. The aromatase inhibitor, letrozole, has been used for induction of ovulation. The purpose of this study was to compare the effects of letrozole and clomiphene citrate in induction of ovulation among patients with PCOS undergoing intrauterine insemination. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S6598DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888072PMC
March 2011
10 Reads

Observational Study to Assess the Therapeutic Value of Four Ovarian Hyperstimulation Protocols in IVF After Pituitary Suppression with GnRH Antagonists in Normally Responding Women.

Clin Med Insights Reprod Health 2011 Feb 22;5:1-9. Epub 2011 Feb 22.

Hospital Universitario "La Fe". Avda. Campanar, 21. 46009. Valencia, Spain.

Objective: To compare the clinical results of four different protocols of COH for IVF-ICSI in normovulatory women, using in all cases pituitary suppression with GnRH antagonists.

Materials/methods: A single center, open label, parallel-controlled, prospective, post-authorization study under the approved conditions for use where 305 normal responders women who were candidates to COH were assigned to r-FSH +hp-hMG (n = 51, Group I), hp-hMG (n = 61, Group II), fixed-dose r-FSH (n = 118, Group III), and r-FSH with potential dose adjustment (n = 75, Group IV) to subsequently undergo IVF-ICSI.

Results: During stimulation, Group IV needed significantly more days of stimulation as compared to Group II [8. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMRH.S6339DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888073PMC
February 2011
11 Reads
  • Page 1 of 1